Approval · Notice of Compliance 30636 · 2023
VYALEV: Notice of Compliance 30636
Issued May 3, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30636
- Date
- May 3, 2023
- Company
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VYALEV | 02537702 | Marketed |
Medicinal ingredients
- FOSCARBIDOPA 12 MG per ML
- FOSLEVODOPA 240 MG per ML